A novel streptonigrin type alkaloid from the Streptomyces flocculus CGMCC 4.1223 mutant ΔstnA/Q2. 2022

Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory on Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

Streptonigrin (STN) is a highly functionalized aminoquinone alkaloid with broad and potent antitumor activities. Previously, the biosynthetic gene cluster of STN was identified in Streptomyces flocculus CGMCC 4.1223, revealing an α/β-hydrolase (StnA) and a methyltransferase (StnQ2). In this work, a double mutant ΔstnA/Q2 was constructed by genetic manipulation and produced a novel derivative of STN, named as streptonigramide. Structure of streptonigramide was established by spectroscopic analyses. Its biosynthetic pathway has been proposed as well.

UI MeSH Term Description Entries
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D013308 Streptonigrin Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia. Bruneomycin,Rufocromomycin,Brunemycin,NSC-45383,Nigrin,NSC 45383,NSC45383

Related Publications

Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
January 2017, The Journal of antibiotics,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
September 1990, Journal of industrial microbiology,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
December 1989, Journal of bacteriology,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
May 1984, The Biochemical journal,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
March 1961, Antibiotics & chemotherapy (Northfield, Ill.),
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
February 1984, The Journal of antibiotics,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
November 2007, Natural product research,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
December 2005, The Journal of antibiotics,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
September 2004, Organic letters,
Xiaozheng Wang, and Fei Xu, and Tingting Huang, and Zixin Deng, and Shuangjun Lin
May 2003, The Journal of organic chemistry,
Copied contents to your clipboard!